News | Mammography | January 16, 2019

Digital Mammography Increases Breast Cancer Detection

U.K. study evaluates more than 11 million screening mammograms

Digital Mammography Increases Breast Cancer Detection

January 16, 2019 — The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study appearing in the journal Radiology.1

Digital mammography was introduced into clinical use more than 15 years ago and has been widely adopted due to the numerous advantages it has over its predecessor, screen film mammography.

“Image quality with digital mammography is improved over that of screen film mammography,” said radiologist and study coauthor Rosalind M. Given-Wilson, MBBS, from St. Georges University Hospitals NHS Foundation Trust in London. “In particular, digital mammography provides the ability to visualize calcifications and see through denser tissue, and it allows the reader to adjust the image.”

Given-Wilson and colleagues assessed digital mammography’s impact on cancer detection using data from the 80 facilities of the English National Health Service Breast Cancer Screening Program. The huge trove of data combined with estimates of digital mammography usage enabled the researchers to measure the effect of digital mammography in 11.3 million screening exams in women between the ages of 45 and 70.

The overall cancer detection rate was 14 percent greater with digital mammography, with substantially higher detection of grade 1 and grade 2 invasive cancers — early-stage cancers that could advance to life-threatening disease if not detected and treated early enough.

At first screening exams for women aged 45 to 52, digital mammography increased the overall detection rate by 19 percent. Importantly, the higher sensitivity of digital mammography did not increase the recall rate — the rate at which women are called back for additional screening based on suspicious results.

“This improvement happened in the absence of other changes in the English screening program, such as a change in recall rate or introduction of computer-aided detection, so we can be clear that the increased rate of detection is due to the change in technology,” Given-Wilson said.

Digital mammography increased the detection of some types of cancers more than others. For instance, digital mammography significantly increased the detection of ductal carcinoma in situ (DCIS), an early-stage cancer confined to the milk ducts of the breast, at both first screens and subsequent screens.

“These results confirm that digital mammography is superior to screen film mammography in finding invasive cancers and DCIS,” Given-Wilson said. “Women are more likely to have a cancer detected with a digital mammogram.”

While digital mammography improved detection of grade 1 and 2 cancers, the researchers found no improvement in the detection of grade 3 invasive cancers. Grade 3 cancers are faster-growing and more likely to spread than grade 1 and 2 cancers.

The researchers are looking at the radiological features of grade 3 cancers on digital mammography to see if optimizing the image for these lesions, which are often nonspecific and ill-defined soft tissue densities, can aid detection. They are also studying the relationship between grade 3 cancers and subsequent interval cancers, or cancers that appear between screenings.

For more information: www.pubs.rsna.org/journal/radiology

Reference

1. Blanks R.G., Wallis M.G., Alison R., et al. Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program. Radiology, Dec. 11, 2018. https://doi.org/10.1148/radiol.2018181426

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing